• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于使用小玻璃管进行一维扩散来测量纤溶活性的方法。II. 特别提及以富含纤溶酶原的纤维蛋白原和不含纤溶酶原的纤维蛋白原作为底物时的差异。

A method for the measurement of fibrinolytic activity based on one dimensional diffusion using small glass tubes. II. With special reference to the differences between the use of plasminogen-rich fibrinogen and that of plasminogen-free fibrinogen as the substrates.

作者信息

Yasukouchi T, Fujine M, Kohn S, Sakurama S, Morioka T

出版信息

Thromb Haemost. 1977 Jun 30;37(3):456-63.

PMID:578026
Abstract

The optimal conditions for the measurement of the fibrinolytic factors of plasma were examined using human and bovine plasminogen-rich fibrinogen or plasminogen-free fibrinogen as the substrates using the one dimensional diffusion method. The results were as follows: 1. There was no essential difference found between using human or bovine fibrinogen. 2. The levels of proactivator-plasminogen and plasminogen could be measured while using either plasminogen-rich or plasminogen-free fibrinogen. But, in using the latter, the proactivator-plasminogen level could not be measured, if a final concentration of more than 2,000 Christensen units of streptokinase were employed. 3. When using plasminogen-rich fibrinogen, anti-plasmin(s) and anti-activator(s) could be measured while using urokinase and plasmin, but not while using streptokinase. However, further study should be given to the measurement of the inhibitors, when using plasminogen-free fibrinogen.

摘要

采用一维扩散法,以富含人及牛纤溶酶原的纤维蛋白原或无纤溶酶原的纤维蛋白原为底物,研究血浆纤溶因子测定的最佳条件。结果如下:1. 使用人或牛纤维蛋白原之间未发现本质差异。2. 使用富含纤溶酶原或无纤溶酶原的纤维蛋白原均可测定前激活物-纤溶酶原和纤溶酶原水平。但是,使用后者时,如果链激酶的终浓度超过2000克里斯滕森单位,则无法测定前激活物-纤溶酶原水平。3. 使用富含纤溶酶原的纤维蛋白原时,使用尿激酶和纤溶酶可测定抗纤溶酶和抗激活物,但使用链激酶时则不能。然而,使用无纤溶酶原的纤维蛋白原时,对抑制剂的测定应进一步研究。

相似文献

1
A method for the measurement of fibrinolytic activity based on one dimensional diffusion using small glass tubes. II. With special reference to the differences between the use of plasminogen-rich fibrinogen and that of plasminogen-free fibrinogen as the substrates.一种基于使用小玻璃管进行一维扩散来测量纤溶活性的方法。II. 特别提及以富含纤溶酶原的纤维蛋白原和不含纤溶酶原的纤维蛋白原作为底物时的差异。
Thromb Haemost. 1977 Jun 30;37(3):456-63.
2
Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.用尿激酶和链激酶治疗深静脉血栓形成期间的全身纤维蛋白溶解活性和抑制剂水平。
Thromb Haemost. 1983 Oct 31;50(3):664-8.
3
[Index of fibrinolysis with new fibrin plate (author's transl)].新型纤维蛋白平板法纤维蛋白溶解指数(作者译)
Nihon Seirigaku Zasshi. 1977;39(1):1-11.
4
In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.使用血栓弹力图法对纤溶酶原激活剂的纤溶活性进行体外比较:在犬模型中使用预滴定剂量对B链-链激酶复合物进行体内评估。
Thromb Haemost. 1986 Aug 20;56(1):71-9.
5
On the reliability of plasminogen measurement employing the proactivator-activator converting method.关于采用前活化剂-活化剂转化法进行纤溶酶原测定的可靠性
Thromb Haemost. 1976 Dec 31;36(3):551-65.
6
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
7
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.急性缺血性心脏病患者的纤维蛋白溶解。特别提及组织型纤溶酶原激活剂治疗对纤维蛋白溶解、凝血和补体途径的全身影响。
Dan Med Bull. 1993 Sep;40(4):383-408.
8
[Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].[人血浆纤维蛋白溶解中的前激活剂-激活剂系统:关于从人血浆中分离出的由功能纯的纤维蛋白原、纤溶酶原和前激活剂组成的合成纤维蛋白溶解系统的研究]
Nihon Seirigaku Zasshi. 1972 Mar;34(3):147-55.
9
[Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)].[纤维蛋白溶解系统(纤溶酶原激活物-激活剂、纤溶酶原-纤溶酶、抗纤溶酶、抗激活剂)的分析研究方法(文献综述)]
Lab Delo. 1976(5):276-83.
10
A new method based on one dimensional diffusion using small glass tubes for the measurement of fibrinolytic activity. I. Fibrinolytic activity of plasmin and "euglobulin + streptokinase".一种基于使用小玻璃管进行一维扩散的测量纤维蛋白溶解活性的新方法。I. 纤溶酶和“优球蛋白+链激酶”的纤维蛋白溶解活性
Thromb Diath Haemorrh. 1972 Dec 31;28(3):329-41.